{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:28:45Z","timestamp":1782206925645,"version":"3.54.5"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.gtc.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T04:30:18Z","timestamp":1494649818000},"page":"345-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Autoimmune Hepatitis Overlap Syndromes and Liver Pathology"],"prefix":"10.1016","volume":"46","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herschel A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2017.01.008_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1089-3261(02)00022-3","article-title":"The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants","volume":"6","author":"Carpenter","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib4","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.01.008_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.gtc.2017.01.008_bib6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02093820","article-title":"Validation of scoring system for diagnosis of autoimmune hepatitis","volume":"41","author":"Czaja","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib13","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib14","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","article-title":"Cholestatic phenotypes of autoimmune hepatitis","volume":"12","author":"Czaja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1089-3261(02)00007-7","article-title":"Autoimmune hepatitis and overlap syndromes","volume":"6","author":"Dienes","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11894-999-0089-0","article-title":"Variant forms of autoimmune hepatitis","volume":"1","author":"Czaja","year":"1999","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gtc.2017.01.008_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease","volume":"31","author":"Heurgue","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gtc.2017.01.008_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0676.1984.tb00914.x","article-title":"Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology","volume":"4","author":"Ludwig","year":"1984","journal-title":"Liver"},{"key":"10.1016\/j.gtc.2017.01.008_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(80)90131-6","article-title":"Clinicopathologic features of the syndrome of primary sclerosing cholangitis","volume":"79","author":"Wiesner","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.01.008_bib21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","article-title":"Autoimmune cholangitis within the spectrum of autoimmune liver disease","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib22","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","article-title":"Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis","volume":"31","author":"Kenny","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib25","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2013\/198070","article-title":"Diagnosis and management of the overlap syndromes of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.1840060403","article-title":"Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis","volume":"6","author":"Ludwig","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","article-title":"Autoimmune hepatitis and its variant syndromes","volume":"49","author":"Ben-Ari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.01.008_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.01.008_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.01.008_bib39","first-page":"339","article-title":"Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience","volume":"39","author":"Kanzler","year":"2001","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","author":"Czaja","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib41","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.01.008_bib42","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","article-title":"Autoimmune liver diseases in children - What is different from adulthood?","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib46","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","article-title":"Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis","volume":"21","author":"Nezu","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib47","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","article-title":"Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?","volume":"42","author":"Gatselis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-4-3","article-title":"The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders","volume":"4","author":"Papamichalis","year":"2007","journal-title":"J\u00a0Autoimmune Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"9","author":"Bonder","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib52","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2013.12.010","article-title":"Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic Acid than non-Hispanics","volume":"12","author":"Levy","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib54","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis","volume":"35","author":"Michieletti","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.01.008_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000478-199401000-00009","article-title":"Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis","volume":"18","author":"Taylor","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gtc.2017.01.008_bib56","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/BF02065530","article-title":"Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases","volume":"40","author":"Goodman","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0025-6196(11)63653-7","article-title":"Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity?","volume":"73","author":"Sherlock","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2017.01.008_bib58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.gtc.2017.01.008_bib59","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cgh.2009.07.012","article-title":"Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease","volume":"7","author":"Milkiewicz","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib61","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","article-title":"Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis","volume":"12","author":"Ozaslan","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib62","first-page":"567","article-title":"Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.gtc.2017.01.008_bib63","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.gtc.2017.01.008_bib65","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib66","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouilleres","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib67","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib68","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1872-034X.2011.00844.x","article-title":"Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome: a rationale for corticosteroids use based on a nation-wide retrospective study in Japan","volume":"41","author":"Tanaka","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.gtc.2017.01.008_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"Luth","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib70","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib72","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1365-2036.2011.04863.x","article-title":"High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis","volume":"34","author":"Imam","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.01.008_bib73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes","volume":"34","author":"Baven-Pronk","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.01.008_bib75","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A","volume":"40","author":"Duclos-Vallee","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.autrev.2011.09.006","article-title":"Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome","volume":"11","author":"Efe","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.008_bib77","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A\u00a0real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.01.008_bib78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhep.2009.03.011","article-title":"Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree","volume":"51","author":"Czaja","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib79","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","article-title":"Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease","volume":"39","author":"Czaja","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib80","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib81","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/egh.11.45","article-title":"Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy","volume":"5","author":"Fallatah","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib82","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ajmg.a.33934","article-title":"An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses","volume":"155A","author":"Lin","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gtc.2017.01.008_bib83","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/egh.12.38","article-title":"Drug choices in autoimmune hepatitis: part B - nonsteroids","volume":"6","author":"Czaja","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib84","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","article-title":"Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC","volume":"9","author":"Geier","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib85","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis","volume":"119","author":"Czaja","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.01.008_bib86","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/egh.12.40","article-title":"Drug choices in autoimmune hepatitis: part A - steroids","volume":"6","author":"Czaja","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib87","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib88","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1155\/2012\/512132","article-title":"Autoimmune hepatitis: focusing on treatments other than steroids","volume":"26","author":"Czaja","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.01.008_bib90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-1007301","article-title":"A\u00a039 year old man with chronic hepatitis","volume":"14","author":"Lawrence","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib91","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2005.11.037","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries","volume":"44","author":"Czaja","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib92","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2017.01.008_bib93","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib94","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1023\/A:1010620122567","article-title":"A\u00a0case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases","volume":"46","author":"Burak","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2017.01.008_bib95","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-200510000-00011","article-title":"Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective","volume":"17","author":"Kingham","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.01.008_bib96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJGM.S11201","article-title":"Overlap of primary biliary cirrhosis and primary sclerosing cholangitis - a rare coincidence or a new syndrome","volume":"3","author":"Jeevagan","year":"2010","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.gtc.2017.01.008_bib97","first-page":"429","article-title":"Overlapping of primary biliary cirrhosis and small duct primary sclerosing cholangitis: first case report","volume":"4","author":"Oliveira","year":"2012","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.gtc.2017.01.008_bib98","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.dld.2015.02.002","article-title":"The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis","volume":"47","author":"Floreani","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gtc.2017.01.008_bib99","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"AASLD Practice Guidelines. Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2017.01.008_bib100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:17:25Z","timestamp":1719199045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855317300195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0889855317300195"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2017.01.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Hepatitis Overlap Syndromes and Liver Pathology","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}